EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database

Pietro Emiliano Doneddu, Luca Gentile, Dario Cocito iD, Raffaella Fazio, Marco Luigetti iD, Chiara Briani iD, Massimiliano Filosto iD, Gabriele Siciliano, Luana Benedetti iD, Giovanni Antonini, Sabrina Matà, Girolama Alessandra Marfia und 22 weitere

European Journal of Neurology · 2024

DOI: 10.1111/ene.16248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Pietro Emiliano Doneddu und 33 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular and Neuroimmunology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy. Hauptthemen laut MEDLINE: Polyneuropathies, Motor Neuron Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Baxalta (Takeda), IRCCS, Humanitas Research Hospital (Rozzano, Milan, Italy), Takeda Pharmaceutical Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose This study aimed to assess the diagnostic criteria, ancillary investigations and treatment response using real‐life data in multifocal motor neuropathy (MMN) patients.

Methods

Clinical and laboratory data were collected from 110 patients enrolled in the Italian MMN database through a structured questionnaire. Twenty‐six patients were excluded due to the unavailability of nerve conduction studies or the presence of clinical signs and symptoms and electrodiagnostic abnormalities inconsistent with the MMN diagnosis. Analyses were conducted on 73 patients with a confirmed MMN diagnosis and 11 patients who did not meet the diagnostic criteria.

Results

The European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) diagnostic criteria were variably applied. AUTHOR:When applying the American Association of Electrodiagnostic Medicine criteria, an additional 17% of patients fulfilled the criteria for probable/definite diagnosis whilst a further 9.5% missed the diagnosis. In 17% of the patients only compound muscle action potential amplitude, but not area, was measured and subsequently recorded in the database by the treating physician. Additional investigations, including anti‐GM1 immunoglobulin M antibodies, cerebrospinal fluid analysis, nerve ultrasound and magnetic resonance imaging, supported the diagnosis in 46%–83% of the patients. Anti‐GM1 immunoglobulin M antibodies and nerve ultrasound demonstrated the highest sensitivity. Additional tests were frequently performed outside the EFNS/PNS guideline recommendations.

Conclusions

This study provides insights into the real‐world diagnostic and management strategies for MMN, highlighting the challenges in applying diagnostic criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolyneuropathiesMotor Neuron DiseaseHumansPeripheral NervesMagnetic Resonance ImagingImmunoglobulin MItalyNeural Conduction

Stichwörter der Autor:innen

MMNdiagnosisdiagnostic criteriaguidelinesmultifocal motor neuropathy

Substanzen

Immunoglobulin M

Autor:innen und Institutionen

  • Neuromuscular and Neuroimmunology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • Department of Clinical and Experimental Medicine, Unit of Neurology, University of Messina, Messina, Italy.
  • Department of Clinical and Biological Sciences, University of Torino, Torino, Italy.
  • Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Milano, Italy.
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Neurologia, Roma, Italy.

ORCID-Profile: Dario Cocito, Marco Luigetti, Chiara Briani, Massimiliano Filosto, Luana Benedetti, Fiore Manganelli, Angela Romano, Luca Leonardi, Elisa Vegezzi, Vincenzo Di Stefano, Eduardo Nobile-Orazio

Förderung

  • Baxalta (Takeda)
  • IRCCS, Humanitas Research Hospital (Rozzano, Milan, Italy)
  • Takeda Pharmaceutical Company

Zitieren

APA

Doneddu, P. E., Gentile, L., Cocito, D., Fazio, R., Luigetti, M., Briani, C., Filosto, M., Siciliano, G., Benedetti, L., Antonini, G., Matà, S., Marfia, G. A., Inghilleri, M., Manganelli, F., Cosentino, G., Brighina, F., Carpo, M., Carta, F., Mazzeo, A., …, & Nobile-Orazio, E. (2024). Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database. European Journal of Neurology. https://doi.org/10.1111/ene.16248

Vancouver

Doneddu PE, Gentile L, Cocito D, Fazio R, Luigetti M, Briani C, et al. Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database. European Journal of Neurology. 2024. doi:10.1111/ene.16248

BibTeX
@article{Doneddu2024,
  author = {Doneddu, Pietro Emiliano and Gentile, Luca and Cocito, Dario and Fazio, Raffaella and Luigetti, Marco and Briani, Chiara and Filosto, Massimiliano and Siciliano, Gabriele and Benedetti, Luana and Antonini, Giovanni and Matà, Sabrina and Marfia, Girolama Alessandra and Inghilleri, Maurizio and Manganelli, Fiore and Cosentino, Giuseppe and Brighina, Filippo and Carpo, Marinella and Carta, Francesca and Mazzeo, Anna and Peci, Erdita and Strano, Camilla and Romano, Angela and Campagnolo, Marta and Cotti-Piccinelli, Stefano and Viola, Divina Valeria and Germano, Francesco and Leonardi, Luca and Sperti, Martina and Mataluni, Giorgia and Ceccanti, Marco and Spina, Emanuele and Vegezzi, Elisa and Di Stefano, Vincenzo and Nobile-Orazio, Eduardo},
  title = {Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database},
  journal = {European Journal of Neurology},
  year = {2024},
  doi = {10.1111/ene.16248}
}
Kostenlos starten →